Welcome to LookChem.com Sign In|Join Free

CAS

  • or

164365-88-2

Post Buying Request

164365-88-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

164365-88-2 Usage

Description

4-(BOC-AMINO)BUTYL BROMIDE, also known as N-Boc-4-aminobutylbromide, is an organic compound with the chemical formula C9H18BrNO2. It is an off-white low melting solid and is primarily used as a synthetic intermediate in the pharmaceutical industry. Its chemical structure allows it to be a versatile building block for the development of various pharmaceutical compounds.

Uses

Used in Pharmaceutical Industry:
4-(BOC-AMINO)BUTYL BROMIDE is used as a synthetic intermediate for the development of various pharmaceutical compounds.
Used in Glaucoma Treatment:
In the field of ophthalmology, 4-(BOC-AMINO)BUTYL BROMIDE is used as a precursor to N-Boc-aminoalkoxyphenyl derivatives, which are pharmacophore elements for the treatment of glaucoma. These derivatives help in the development of novel therapeutic agents that can effectively manage intraocular pressure, a key factor in glaucoma progression.
Used in Anti-HIV Applications:
4-(BOC-AMINO)BUTYL BROMIDE is utilized in the synthesis of various aloperine derivatives, which have potential applications as anti-HIV agents. These derivatives target specific enzymes or receptors in the HIV virus, inhibiting its replication and reducing the viral load in infected individuals.
Used in CK2 Inhibitors Development:
In the realm of enzyme inhibition, 4-(BOC-AMINO)BUTYL BROMIDE is used for the modification of 4,5,6,7-tetrabromobenzotriazole (TBB) derivatives to generate improved CK2 inhibitors. CK2, or casein kinase 2, is a protein kinase involved in various cellular processes, and its inhibition has been linked to the regulation of cancer cell growth. The modified TBB derivatives can potentially serve as lead compounds in the development of novel anticancer drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 164365-88-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,4,3,6 and 5 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 164365-88:
(8*1)+(7*6)+(6*4)+(5*3)+(4*6)+(3*5)+(2*8)+(1*8)=152
152 % 10 = 2
So 164365-88-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H18BrNO2/c1-9(2,3)13-8(12)11-7-5-4-6-10/h4-7H2,1-3H3,(H,11,12)

164365-88-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (90303)  4-(Boc-amino)butylbromide  technical, ≥90% (AT)

  • 164365-88-2

  • 90303-500MG-F

  • 1,036.62CNY

  • Detail
  • Aldrich

  • (90303)  4-(Boc-amino)butylbromide  technical, ≥90% (AT)

  • 164365-88-2

  • 90303-2.5G-F

  • 3,621.15CNY

  • Detail

164365-88-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-(4-bromobutyl)carbamate

1.2 Other means of identification

Product number -
Other names tert-butyl 4-bromobutylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:164365-88-2 SDS

164365-88-2Relevant articles and documents

Influence of calcium-induced aggregation on the sensitivity of aminobis(methylenephosphonate)-containing potential MRI contrast agents

Henig, Joerg,Mamedov, Ilgar,Fouskova, Petra,Toth, Eva,Logothetis, Nikos K.,Angelovski, Goran,Mayer, Hermann A.

, p. 6472 - 6481 (2011)

A novel class of 1,4,7,10-tetraazacyclododecane-1,4,7- tris(methylenecarboxylic) acid (DO3A)-based lanthanide complexes with relaxometric response to Ca2+ was synthesized, and their physicochemical properties were investigated. Four macrocyclic ligands containing an alkyl-aminobis(methylenephosphonate) side chain for Ca 2+-chelation have been studied (alkyl is propyl, butyl, pentyl, and hexyl for L1, L2, L3, and L4, respectively). Upon addition of Ca2+, the r1 relaxivity of their Gd3+ complexes decreased up to 61% of the initial value for the best compounds GdL3 and GdL4. The relaxivity of the complexes was concentration dependent (it decreases with increasing concentration). Diffusion NMR studies on the Y3+ analogues evidenced the formation of agglomerates at higher concentrations; the aggregation becomes even more important in the presence of Ca2+. 31P NMR experiments on EuL1 and EuL4 indicated the coordination of a phosphonate to the Ln3+ for the ligand with a propyl chain, while phosphonate coordination was not observed for the analogue bearing a hexyl linker. Potentiometric titrations yielded protonation constants of the Gd 3+ complexes. log KH1 values for all complexes lie between 6.12 and 7.11 whereas log KH2 values are between 4.61 and 5.87. Luminescence emission spectra recorded on the Eu3+ complexes confirmed the coordination of a phosphonate group to the Ln3+ center in EuL1. Luminescence lifetime measurements showed that Ca-induced agglomeration reduces the hydration number which is the main cause for the change in r1. Variable temperature 17O NMR experiments evidenced high water exchange rates on GdL1, GdL2, and GdL3 comparable to that of the aqua ion.

Self-Assembly of Stimuli-Responsive [2]Rotaxanes by Amidinium Exchange

Borodin, Oleg,Richter, Stefan,Robertson, Craig C.,Shchukin, Yevhenii,Von Delius, Max

supporting information, p. 16448 - 16457 (2021/10/12)

Advances in supramolecular chemistry are often underpinned by the development of fundamental building blocks and methods enabling their interconversion. In this work, we report the use of an underexplored dynamic covalent reaction for the synthesis of stimuli-responsive [2]rotaxanes. The formamidinium moiety lies at the heart of these mechanically interlocked architectures, because it enables both dynamic covalent exchange and the binding of simple crown ethers. We demonstrated that the rotaxane self-assembly follows a unique reaction pathway and that the complex interplay between crown ether and thread can be controlled in a transient fashion by addition of base and fuel acid. Dynamic combinatorial libraries, when exposed to diverse nucleophiles, revealed a profound stabilizing effect of the mechanical bond as well as intriguing reactivity differences between seemingly similar [2]rotaxanes.

DECONSTRUCTIVE FUNCTIONALIZATION METHODS AND COMPOUNDS

-

Paragraph 0482-0485, (2020/01/31)

Disclosed herein, inter alia, are deconstructive functionalization methods and compounds made using the same.

COVALENT TARGETING OF E3 LIGASES

-

Paragraph 0591; 0649, (2020/05/19)

Disclosed herein, inter alia, are compositions and methods for targeting E3 ligases. In an aspect is a targeted protein degrader including 1) a targeted protein binder and 2) an E3 Ubiquitin ligase binder, wherein the E3 Ubiquitin ligase is human RNF4 or human RNF114. In an aspect is provided a pharmaceutical composition including a compound as described herein, including embodiments, and a pharmaceutically acceptable excipient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 164365-88-2